Filtered By:
Vaccination: AIDS Vaccine
This page shows you your search results in order of relevance. This is page number 17.
Order by Relevance | Date
Total 480 results found since Jan 2013.
The Clear And Present Menace Of SciLence
I heard from a public health colleague this week, whose work and time are partly funded by the Centers for Disease Control and Prevention, that the CDC did not want to be acknowledged as a funding source in a research paper addressing gun violence. Apparently, CDC scientists have marching orders to be more concerned about unflattering facts about gun violence, than about gun violence itself. That’s ideology 1, epidemiology 0.The score does not improve after that. In high-profile media coverage you have likely seen, we learned that the Trump Administration had, in an early indication of its ominous priorities, effectiv...
Source: Science - The Huffington Post - January 27, 2017 Category: Science Source Type: news
OBK-17-0008 Does Zika Virus Cause Microcephaly – Applying the Bradford Hill Viewpoints
This study included more recent evidence compared to the previous one.
The Bradford-Hill Viewpoints are used in public health to determine causation of diseases.11 Systematic application of the viewpoints can assist with analysing a possible causal relationship. Additional studies to assess the risk of microcephaly in affected pregnant mothers are ongoing.12 In this study we applied the Bradford-Hill viewpoints to investigate the association between Zika virus and Microcephaly.
Method
Using the Bradford Hills nine viewpoints we analysed data from a 2013 outbreak in French Polynesia and the 2015 Brazilian outbreak to esta...
Source: PLOS Currents Outbreaks - February 22, 2017 Category: Epidemiology Authors: asma Source Type: research
Does Zika Virus Cause Microcephaly – Applying the Bradford Hill Viewpoints
This study included more recent evidence compared to the previous one.
The Bradford-Hill Viewpoints are used in public health to determine causation of diseases.11 Systematic application of the viewpoints can assist with analysing a possible causal relationship. Additional studies to assess the risk of microcephaly in affected pregnant mothers are ongoing.12 In this study we applied the Bradford-Hill viewpoints to investigate the association between Zika virus and Microcephaly.
Method
Using the Bradford Hills nine viewpoints we analysed data from a 2013 outbreak in French Polynesia and the 2015 Brazilian outbreak to esta...
Source: PLOS Currents Outbreaks - February 22, 2017 Category: Epidemiology Authors: asma Source Type: research
Avoid Patent Clauses in Trade Treaties that can Kill Millions
Credit: BigstockBy Martin KhorPENANG, Feb 27 2017 (IPS)Recently a very interesting article on why there are inequalities in access to health care and how medicine prices are beyond the reach of many people was published in The Lancet, one of the most prestigious medical journals in the world.The authors, who are eminent experts in development and public health, pinpointed trade and investment agreements for being one of the greatest health threats.Reading their powerful commentary leads one to think: What’s the point of having wonderful medicines if most people on Earth cannot get to use them? And isn’t it immo...
Source: IPS Inter Press Service - Health - February 27, 2017 Category: Global & Universal Authors: Martin Khor Tags: Economy & Trade Headlines Health Trade & Investment Trans-Pacific Partnership (TPP) World Trade Organization (WTO) Source Type: news
Scripps Florida Scientist awarded $4.8 million to bring HIV vaccine closer to human trials
(Scripps Research Institute) Professor Michael Farzan, co-chair of the Department of Immunology and Microbiology on the Florida campus of The Scripps Research Institute (TSRI) has received $4.8 million in funding through a 2017 Avant-Garde Award for HIV/AIDS research from the National Institutes of Health's National Institute on Drug Abuse (NIDA). The new funding will support a five-year project, led by Farzan, to bring a potential HIV vaccine closer to human clinical trials.
Source: EurekAlert! - Medicine and Health - April 11, 2017 Category: Global & Universal Source Type: news
The World Is Not Ready for the Next Pandemic
Across China, the virus that could spark the next pandemic is already circulating. It’s a bird flu called H7N9, and true to its name, it mostly infects poultry. Lately, however, it’s started jumping from chickens to humans more readily–bad news, because the virus is a killer. During a recent spike, 88% of people infected got pneumonia, three-quarters ended up in intensive care with severe respiratory problems, and 41% died.
What H7N9 can’t do–yet–is spread easily from person to person, but experts know that could change. The longer the virus spends in humans, the better the chance that i...
Source: TIME.com: Top Science and Health Stories - May 4, 2017 Category: Consumer Health News Authors: Bryan Walsh Tags: Uncategorized CDC Disease ebola Gates Foundation MERS outbreak pandemic Zika Source Type: news
Sorting out HIV
(European Molecular Biology Laboratory) Researchers at EMBL, ESPCI Paris, and the International AIDS Vaccine Initiative have developed a new technique for rapidly sorting HIV viruses, which could lead to more rapid development of a vaccine for HIV, as they report in Cell Chemical Biology.The technique will enable scientists to identify specific features in the proteins on the virus's surface which are recognized by the immune system and elicit a response similar to that seen in elite controllers -- patients that are able to survive without antiviral treatment.
Source: EurekAlert! - Medicine and Health - May 25, 2017 Category: International Medicine & Public Health Source Type: news
CROI 2017: Advances in Antiretroviral Therapy.
Authors: Jones J, Taylor BS, Tieu HV, Wilkin TJ
Abstract
The 2017 Conference on Retroviruses and Opportunistic Infections (CROI) featured exciting preclinical data on investigational antiretroviral agents with good in vitro efficacy and long half-lives. Investigational medications, including bictegravir, demonstrated excellent efficacy and tolerability, as did dual-agent therapy with dolutegravir paired with rilpivirine or with lamivudine. Dolutegravir monotherapy proved inadvisable due to virologic failure and resistance. The gap between high- and low-income settings along the HIV care continuum is narrowing, with...
Source: Topics in antiviral medicine - June 10, 2017 Category: Infectious Diseases Tags: Top Antivir Med Source Type: research
Cow antibodies yield important clues for developing a broadly effective AIDS vaccine
(International AIDS Vaccine Initiative) As outlined in a study published today in Nature, lead author Devin Sok, Director, Antibody Discovery and Development at the International AIDS Vaccine Initiative (IAVI), reports the elicitation of powerful, HIV-blocking antibodies in cows in a matter of weeks - a process that usually takes years in humans. The unexpected animal model is providing clues for important questions at a moment when new energy has infused HIV vaccine research.
Source: EurekAlert! - Medicine and Health - July 20, 2017 Category: International Medicine & Public Health Source Type: news
Africa: Trump's Proposed Health Research Cuts Putting Millions at Risk
[Global Health Techonologies Coalition] In just eight years, $14 billion in public spending returned $33 billion to US economy, delivering malaria and meningitis breakthroughs, and advancing AIDS vaccine research
Source: AllAfrica News: Health and Medicine - July 20, 2017 Category: African Health Source Type: news
HIV fight advances with new drug cocktails, fresh vaccine hopes
LONDON (Reuters) - Three decades after approval of the first-ever AIDS treatment, HIV medicine is seeing a new wave of innovation with scientists reporting positive data on Monday for improved drug cocktails and a novel experimental vaccine.
Source: Reuters: Health - July 24, 2017 Category: Consumer Health News Tags: healthNews Source Type: news
HIV Fight Advances With New Drug Cocktails, Fresh Vaccine Hopes HIV Fight Advances With New Drug Cocktails, Fresh Vaccine Hopes
Three decades after approval of the first-ever AIDS treatment, HIV medicine is seeing a new wave of innovation with scientists reporting positive data on Monday for improved drug cocktails and a novel experimental vaccine.Reuters Health Information
Source: Medscape Hiv-Aids Headlines - August 4, 2017 Category: Infectious Diseases Tags: HIV/AIDS News Source Type: news
Fighting HIV on Multiple Fronts Might Lead to Vaccine
Combination strategy fully protects lab monkeys, studies find
Source: Fertility News - Doctors Lounge - September 20, 2017 Category: Reproduction Medicine Tags: Infections, AIDS, Reproductive Medicine, Research, News, Source Type: news
Predictors for and Coverage of Flu Vaccine in HIV Patients Predictors for and Coverage of Flu Vaccine in HIV Patients
How likely are HIV-infected individuals to be vaccinated against influenza, and what are the reasons for not doing so? A survey of HIV-positive patients provides insight.HIV Medicine
Source: Medscape Hiv-Aids Headlines - September 25, 2017 Category: Infectious Diseases Tags: HIV/AIDS Journal Article Source Type: news
Trispecific broadly neutralizing HIV antibodies mediate potent SHIV protection in macaques
The development of an effective AIDS vaccine has been challenging because of viral genetic diversity and the difficulty of generating broadly neutralizing antibodies (bnAbs). We engineered trispecific antibodies (Abs) that allow a single molecule to interact with three independent HIV-1 envelope determinants: the CD4 binding site, the membrane-proximal external region (MPER), and the V1V2 glycan site. Trispecific Abs exhibited higher potency and breadth than any previously described single bnAb, showed pharmacokinetics similar to those of human bnAbs, and conferred complete immunity against a mixture of simian-human immuno...
Source: ScienceNOW - October 5, 2017 Category: Science Authors: Xu, L., Pegu, A., Rao, E., Doria-Rose, N., Beninga, J., McKee, K., Lord, D. M., Wei, R. R., Deng, G., Louder, M., Schmidt, S. D., Mankoff, Z., Wu, L., Asokan, M., Beil, C., Lange, C., Leuschner, W. D., Kruip, J., Sendak, R., Do Kwon, Y., Zhou, T., Chen, X Tags: Immunology, Medicine, Diseases, Virology r-articles Source Type: news
